Injectable platelet rich fibrin therapy for androgenetic alopecia: a series of 15 cases


  • Ketki S. Bhoite Seth G. S. Medical College and K.E.M Hospital, Mumbai, Maharashtra, India
  • Siddhi B. Chikhalkar Seth G. S. Medical College and K.E.M Hospital, Mumbai, Maharashtra, India
  • Sunil N. Mishra L. H. Hiranandani Hospital, Mumbai, Maharashtra, India
  • Vidya D. Kharkar Seth G. S. Medical College and K.E.M Hospital, Mumbai, Maharashtra, India



Androgenetic alopecia, Injectable platelet rich fibrin, Stem cells, Platelets


Androgen dependent hair loss is the most common cause of progressive hair loss due to androgenetic miniaturization of hair follicles. Grade 1 and 2 of alopecia is managed well with topical and oral modalities, however grade 3 onwards the need adjuvant treatment arises. To evaluate the efficacy, safety profile and feasibility of injectable-platelet rich fibrin (I-PRF) in androgenetic alopecia and assess the patient satisfaction with this new treatment modality, we conducted a pilot study. Here, 15 patients of androgenetic alopecia were treated with injectable PRF and micro-needling at 2 weekly interval for 4 sittings with a background therapy of minoxidil, finasteride and multivitamin supplements. Monitoring was done with clinical photographs and dermoscopic evaluation prior to each session and a standard assessment questionnaire was given at the end of the study. A significant improvement in hair growth was observed clinically with positive score of 7.42 on the patient satisfaction scale and visible changes were noticed on clinical photographs and dermoscopy. Hence, we concluded that I-PRF is safe, easy, time and cost-effective adjuvant modality for managing androgenetic alopecia with some theoretical advantages over PRP.

Author Biography

Vidya D. Kharkar, Seth G. S. Medical College and K.E.M Hospital, Mumbai, Maharashtra, India



Verma K, Tegta GR, Verma G, Gupta M, Negi A, Sharma R. A study to compare the efficacy of platelet-rich plasma and minoxidil therapy for the treatment of androgenetic alopecia. Int J Trichol. 2019;11:68-79.

Khatu SS, More YE, Gokhale NR, Chavhan DC, Bendsure N. Platelet-rich plasma in androgenic alopecia: Myth or an effective tool. J Cutan Aesthet Surg. 2014;7:107-10

Arora R, Shukla S. Injectable-platelet-rich fibrin-smart blood with stem cells for the treatment of alopecia: A report of three patients. Int J Trichol. 2019;11:128-31.

Choukroun J, Adda F, Schoeffler C, Vervelle A. Une opportunitéen paro-implantologie: Le PRF. Implantodontie. 2001;42:55-62.

Toffler M, Toscano N, Holtzclaw D, Corso MD, Dohan Ehrenfest DM. Introducing Choukroun’s platelet rich fibrin (PRF) to the reconstructive surgery milieu. J Implant Adv Clin Dent. 2009;1:21-30.

Kobayashi E, Flückiger L, Fujioka-Kobayashi M, Sawada K, Sculean A, Schaller B, et al. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Invest. 2016;20:2353-60.

Davis VL, Abukabda AB, Radio NM, Witt-Enderby PA, Clafshenkel WP, Cairone JV, et al. Platelet-rich preparations to improve healing. part i: workable options for every size practice. J Oral Implantol. 2014;5:500-10.

Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet rich fibrin(PRF): A second grneration platelet concentrate. Part II:Platelet related biologic features. Oral Surg Oral Med Oral Pathol Radiol Endod. 2006;101:e45-50.

Vinaya KR, Shubhashini N. Platelet rich fibrin: A new paradigm in periodontal regeneration. Cell Tissue Bank. 2012.

Ghanaati S, Booms P, Orlowska A, Kubesch A, Lorenz J, Rutkowski J, et al. Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. J Oral Implantol. 2014;40:679-89.

Etulain J. Platelets in wound healing and regenerative medicine. Platelets. 2018;29(6):556-68.

Dhurat R, Sukesh M. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective J Cutan Aesthet Surg. 2014;7(4):189-97

Barber BI, Kaufman KD, Kozloff RC, Girman CJ, Guess HA. A hair growth Questionnaire for use in the evaluation of therapeutic effects in men. J Dermatol Treat. 1998;9:3:181-6.






Case Series